PKCδ/EGFR axis-dependent SGLT1 upregulation is a key mechanism for acquired resistance to EGFR-TKI, and increased glucose uptake in NSCLC cells (Chen et al., 2021a). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.